Pharmacological Interventions and Rehabilitation Approach for Enhancing Brain Self-repair and Stroke Recovery

• Published in: Current neuropharmacology Vol. 18; no. 1; pp. 51 - 64
• Main Authors: Szelenberger, Rafał, Kostka, Joanna, Saluk-Bijak, Joanna, Miller, Elżbieta
• Format: Journal Article
• Language: English
• Published: United Arab Emirates Bentham Science Publishers Ltd 01.01.2020; Benham Science Publishers; Bentham Science Publishers
• Subjects: Animals; Behavioral plasticity; Brain - drug effects; Brain Injuries - drug therapy; Brain Injuries - therapy; Cell- and Tissue-Based Therapy; Citicoline; Cognitive ability; Combined Modality Therapy; Electromagnetic fields; Fluoxetine; Functional morphology; Functional plasticity; Humans; Levodopa; Low frequency; Neuronal Plasticity; Neuropharmacology; Neuroprotection; Neuroprotection - drug effects; Neuroprotective Agents - pharmacology; Recovery of Function - drug effects; Rehabilitation; Stroke; Stroke - drug therapy; Stroke - therapy; Structure-function relationships; Stroke; rehabilitation; recovery; stem cell; drugs; neuroprotection
• ISSN: 1570-159X; 1875-6190
• DOI: 10.2174/1570159X17666190726104139

Neuroplasticity is a natural process occurring in the brain for the entire life. Stroke is the leading cause of long term disability and a huge medical and financial problem throughout the world. Research conducted over the past decade focused mainly on neuroprotection in the acute phase of stroke while very little studies target the chronic stage. Recovery after stroke depends on the ability of our brain to reestablish the structural and functional organization of neurovascular networks. Combining adjuvant therapies and drugs may enhance the repair processes and restore impaired brain functions. Currently, there are some drugs and rehabilitative strategies that can facilitate brain repair and improve clinical effect even years after stroke onset. Moreover, some of the compounds such as citicoline, fluoxetine, niacin, levodopa, etc. are already in clinical use or are being trialed in clinical issues. Many studies are also testing cell therapies; in our review, we focused on studies where cells have been implemented at the early stage of stroke. Next, we discuss pharmaceutical interventions. In this section, we selected methods of cognitive, behavioral, and physical rehabilitation as well as adjuvant interventions for neuroprotection including noninvasive brain stimulation and extremely low-frequency electromagnetic field. The modern rehabilitation represents a new model of physical interventions with the limited therapeutic window up to six months after stroke. However, previous studies suggest that the time window for stroke recovery is much longer than previously thought. This review attempts to present the progress in neuroprotective strategies, both pharmacological and non-pharmacological that can stimulate the endogenous neuroplasticity in post-stroke patients.